Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL

EMBO Journal

Volumn 16, Issue 14, 1997, Pages 4374-4383

  Wang, Li Chun ^a,b   Kuo, Frank ^a   Fujiwara, Yuko ^a,b   Gilliland, D Gary ^a,b   Golub, Todd R ^a   Orkin, Stuart H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Angiogenesis; Apoptosis; Ets transcription factor; Gene targeting; Leukemia

Indexed keywords

TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; HEMATOPOIESIS; MESENCHYME CELL; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; YOLK SAC;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; DNA-BINDING PROTEINS; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; GENE TARGETING; HEMATOPOIESIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; YOLK SAC;

ANIMALIA;

EID: 0030839731     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.14.4374     Document Type: Article

References (66)

1. Baldwin, H.S. et al. (1994) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development, 120, 2539-2553.
2. Bar, T. (1980) The vascular system of the cerebral cortex. Adv. Anat. Embryol., 59, 1-62.
3. Bories, J.-C., Willerford, D., Grevin, D., Davidson, L., Camus, A., Patrick, M., Stehelin, D. and Alt, F.W. (1995) Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature, 377, 635-638.
4. Buijs, A. et al. (1995) Translocation (12:22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene, 10, 1511-1519.
5. Carmeliet, P. et al. (1996a) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439.
6. Carmeliet, P. et al. (1996b) Role of tissue factor in embryonic blood vessel development. Nature, 383, 73-75.
7. Carroll, M., Thomasson, M.H., Barker, G.F., Golub, T.R. and Gilliland, D.G. (1996) The TEL/PDGFRβ fusion in CMML is a transforming protein that self-associates and activates PDGFRβ kinase-dependent signaling pathways. Proc. Natl Acad. Sci. USA, 93, 14845-14850.
8. KIP1. Blood, 86, 3869-3875.
9. Dumont, D.J., Gradwohl, G., Fong, G.-H., Puri, M.C., Gerstenstein, M., Auerbach, A. and Breitman, M.L. (1994) Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev., 8, 1897-1909.
10. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S., Powell-Braxton, L., Hillan, K.J. and Moore, M.W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-442.
11. Folkman, J. and D'Amore, P.A. (1996) Blood vessel formation: what is its molecular basis? Cell, 87, 1153-1155.
12. Fong, G.H., Rossant, J., Gertenstein, M. and Breitman, M.L. (1995) Role of the Fit-1 receptor tyrosine kinase in regulating assembly of vascular endothelium. Nature, 376, 66-70.
13. Galang, C.K., Der, C.J. and Hauser, C.A. (1994) Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites. Oncogene, 9, 2913-2921.
14. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501.
15. Golub, T.R., Barker, G.F., Lovett, M. and Gilliland, D.G. (1994) Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77, 307-316.
16. Golub, T.R. et al. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA, 92, 4917-4921.
17. Golub, T., Goga, A., Barker, G., Afar, D., McLaughlin, J., Bohlander, S., Rowley, J., Witte, O. and Gilliland, D. (1996) Oligomerization of the ABL tyrosine kinase by the ETS protein TEL in human leukemia. Mol. Cell. Biol., 16, 4107-4116.
18. Guo, D., Jia, Q., Song, H.Y., Warren, R.S. and Donner, D.B. (1995) Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem., 270, 6729-6733.
19. Henkemeyer, M., Rossi, D.J., Holmyard, D.P., Puri, M.C., Mbamalu, G., Harpal, K., Shih, T.S., Tacks, T. and Pawson, T. (1995) Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature, 377, 695-701.
20. Hiebert, S.W. et al. (1996) The t(12;21) converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol., 16, 1349-1355.
21. Huang, L., Turck, C.W., Rao, P. and Peters, K.G. (1995) GRB2 and SH-PTP2: potentially important endothelial signal molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene, 11, 2097-2103.
22. Jousset, C., Carron, C., Boureux, A., Quang, C.T., Oury, C., Dousanter-Fourt, I., Charon, M., Levin, J., Bernard, O. and Ghysdael, J. (1997) A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein. EMBO J., 16, 69-82.
23. Keller, G., Kennedy, M., Papayannopoulou, T. and Wiles, M. (1993) Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol., 13, 473-486.
24. Kirby, M.L. and Waldo, K.L. (1995) Neural crest and cardiovascular patterning. Circ. Res., 77, 211-215.
25. Lai, Z. and Rubin, G. (1992) Negative control of photoreceptor development in Drosophila by the product of the van gene, an ETS domain protein. Cell, 70, 609-620.
26. Maltepe, E., Schmidt, J.V., Baunoch, D., Bradfield, C.A. and Simon, M.C. (1997) ARNT is essential for response to oxygen and glucose deprivation and developmental angiogenesis in the mouse. Nature, in press.
27. Maroulakou, I.G., Papas, T.S. and Green, J.E. (1994) Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene, 9, 1551-1565.
28. McKercher, S. et al. (1996) Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J., 15, 5647-5658.
29. McLean, T. et al. (1996) TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood, 88, 4252-4258.
30. Melet, F., Motro, B., Rossi, D.J., Zhang, L. and Bernstein, A. (1996) Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol. Cell. Biol., 16, 2708-2718.
31. Muthusamy, N., Barton, K. and Leiden, J.M. (1995) Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature, 377, 639-642.
32. Nakamura, H. (1988) Electron microscopic study of the prenatal development of the thoracic aorta in the rat. Am. J. Anat., 181, 406-418.
33. O'Neill, E., Rebay, I., Tjian, R. and Rubin, G. (1994) The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell, 78, 137-147.
34. Offermanns, S., Mancino, V., Revel, J.-P. and Simon, M. (1997) Vascular system defects and impaired cell chemokinesis as a result of Gα deficiency. Science, 275, 533-536.
35. Okuda, T., Deursen, J.V., Hiebert, S.W., Grosveld, G. and Downing, J.R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321-330.
36. Papadopoulos, P., Ridge, S.A., Boucher, C.A., Stocking, C. and Wiedemann, L.M. (1995) The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res., 55, 34-38.
37. Pardanaud, L. and Dieterlen-Lièvre, F. (1993) Expression of c-ets-1 in early chick embryo mesoderm-relationship to the hemangioblastic lineage. Cell, Res. Commun., 1, 151-160.
38. Pardanaud, L., Yassine, F. and Dieterlen-Lièvre, F. (1989) Relationship between vasculogenesis, angiogenesis and hematopoiesis during avian ontogeny. Development, 105, 473-485.
39. Poirel, H. et al. (1997) The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene, 14, 349-357.
40. Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F.W. and Orkin, S.H. (1996) The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell, 86, 47-57.
41. Puri, M.C. Rossant, J., Alitalo, K., Berstein, A. and Partanen, J. (1995) The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J., 14, 5884-5891.
42. Raynaud, S.D. et al. (1996a) Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood, 88, 682-689.
43. Raynaud, S.D. et al. (1996b) The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood, 87, 2891-2899.
44. Risau, W. (1995) Differentiation of endothelium. FASEB J., 9, 926-933.
45. Risau, W. and Flamme, I. (1995) Vasculogenesis. Annu. Rev. Cell Dev. Biol., 11, 73-91.
46. Robb, L., Elwood, N.J., Elefanty, A.G., Kon̈tgen, R. Li, R., Barnett, D. and Begley, C.G. (1996) The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J., 15, 4123-4129.
47. Romana, S.P., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R. and Bernard, O.A. (1995a) The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion. Blood, 85, 3662-3670.
48. Romana, S.P., Poirel, H., Leconiat, M., Flexor, M.-A., Machauffe, M., Jonveaux, P., Macintyre, E.A., Berger, R. and Bernard, O.A. (1995b) High frequency of the t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 86, 4263-4269.
49. Sariola, H., Ekblom, P., Lehtonen, E. and Saxen, L. (1983) Differentiation and vascularization of the metanephric kidney grafted on the chorioallantoic membrane. Dev. Biol., 96, 427-435.
50. Sato, T.N. et al. (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature, 376, 70-74.
51. Schlaeger, T.M., Qin, Y. Fujiwara, Y. Magram, J. and Sato, T. (1995) Vascular endothelial cell lineage-specific promoter in transgenic mice. Development, 121, 1089-1098.
52. Scott, E.W., Simon, M.C., Anastasi, J. and Singh, H. (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science, 265, 1573-1577.
53. Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S and Shibuya, M. (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene, 10, 135-147.
54. Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu, X.F., Breitman, M.L. and Schuh, A.C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 376, 62-66.
55. Shivdasani, R., Mayer, E. and Orkin, S.H. (1995) Absence of blood formation in mice lacking the T cell leukemia oncoprotein tal/SCL. Nature, 373, 432-434.
56. Shurtleff, S.A. et al. (1995) TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia, 9, 1985-1989.
57. Stegmaier, K. et al. (1995) Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood, 86, 38-44.
58. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1996) Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis. Cell, 87, 1171-1180.
59. Takeuchi, S. et al. (1996) Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood, 87, 3368-3374.
60. Vikkula, M. et al. (1996) Vascular dysmorphogenesis caused by an activation mutation in the receptor tyrosine kinase TIE2. Cell, 87, 1181-1190.
61. Wang, Q., Stacy, T. Binder, M., Marin-Padilla, M., Sharp, A.H and Speck, N.A. (1996) Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl Acad. Sci. USA, 93, 3444-3449.
62. Warren, A.J., Colledge, W.H., Carlton, M.B.L., Evans, M.J., Smith, A.J.H. and Rabbits, T.H. (1994) The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell, 78, 45-57.
63. Wasylyk, B., Hahn, S.L. and Giovane, A. (1993) The Ets family of transcription factors. Eur. J. Biochem., 211, 7-18.
64. Wilkinson, D.G. (1992) Whole mount in-situ hybridization of vertebrate embryos, In In-Situ Hybridization. IRL Press, Oxford, pp. 75-83.
65. Wong, P.M.C., Chung, S.W., Chui, D.H.K. and Eaves, C.J. (1986) Properties of the earliest clonogenic hematopoietic precursors to appear in the developing murine yolk sac. Proc. Natl Acad. Sci. USA, 83, 3851-3854.
66. Yang, B.-S., Hauser, C.A., Henkel, G., Colman, M.S., Van Beveren, C., Stacey, K.J., Hume, D.A., Maki, R.A. and Ostrowski, M.C. (1996) Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol., 16, 538-547.